Approximately 463 million adults worldwide have diabetes, with diabetic retinopathy affecting up to 35 percent of this population according to World Health Organization data. The burden varies significantly by geographic region, with Sub-Saharan Africa experiencing the highest prevalence at 35.9 percent, followed by the Middle East and North Africa at 31.2 percent. South and Southeast Asia report 28.4 percent prevalence, while Europe and North America show lower rates at 24.1 percent and 18.7 percent respectively.
Proliferative diabetic retinopathy represents the most severe form of this complication, requiring immediate clinical intervention to prevent blindness. The disease develops through a cascade of vascular damage triggered by chronic hyperglycemia, leading to the formation of abnormal blood vessels prone to hemorrhage. These epidemiological data highlight the urgent need for enhanced diabetes management and systematic retinopathy screening programs across all healthcare systems, particularly in regions with higher disease prevalence.
Read the full article on GMJ Newsroom.
Was this article helpful?
